New partnerships in Korea to transform mRNA technology into more vaccines

Gachon University, the Korea mRNA Vaccine Initiative (KmVAC), and the International Vaccine Institute (IVI) recently exc...

January 16, 2023 | Monday | News
World's second developed shingles vaccine receives biologics license application approval in Malaysia

South Korea headquatered SK bioscience, a global innovative vaccine and biotech company, has received a biologics licens...

January 12, 2023 | Thursday | News
Demand booms for experimental mRNA in Australia

The University of Queensland (UQ) team has become the biggest supplier of experimental mRNA vaccines and therapies ...

January 12, 2023 | Thursday | News
IVI, Batavia Biosciences sign MoU for vaccine research and development

The International Vaccine Institute (IVI), a South Korea-based international organisation devoted to vaccines for global...

January 10, 2023 | Tuesday | News
Nasal COVID-19 vaccine stored in NEST Disposable Intranasal Atomisation Device receives EUA in China

On December 2nd, a nasal spray COVID-19 vaccine, VectorFlu ONE, was approved for emergency use (EU) by the national auth...

December 27, 2022 | Tuesday | News
MSD signs pact with Indonesia's Bio Farma for HPV vaccine production

Bio Farma, Holding SOE Pharmacy – with its subsidiaries Kimia Farma and Indofarma, has signed a framework agreemen...

December 20, 2022 | Tuesday | News
China-based biotech startup's mRNA vaccine receives EUA in Laos

Chinese biotech startup Stemirna Therapeutics has received an Emergency Use Authorisation (EUA) from the FDA for ...

December 16, 2022 | Friday | News
Malaysia strives to develop children’s Hexavalent vaccine by 2023

Malaysia's Pharmaniaga LifeScience Sdn Bhd (PLS) and Pharmaniaga Berhad have signed a Research Collaboration Agreem...

December 14, 2022 | Wednesday | News
Moderna to expand Asia-Pacific presence with new Singapore subsidiary

Moderna, Inc., has announced its Singapore subsidiary with a new leadership announcement.  Evelyn Pang has been ap...

December 12, 2022 | Monday | News
Takeda’s dengue tetravalent vaccine QDENGA receives approval in European Union

Japanese pharmaceutical firm Takeda has announced that the European Commission (EC) has granted marketing authorisation ...

December 9, 2022 | Friday | News
CEPI boosts 'Coronavirus X' vaccine search with expanded VBI Vaccines deal

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) is expanding its world-leading portfolio of potentia...

December 8, 2022 | Thursday | News
Vaxxas raises A$34 M to clinically advance needle-free vaccines

Vaxxas has completed a financing round which raised $23 million (A$34 million) in new funds. This investment round was l...

December 6, 2022 | Tuesday | News
Australia takes aim at next pandemic threat with new vaccine platform

Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, is to put $5.7 million (AU$8.5 million) into the...

November 28, 2022 | Monday | News
XtalPi, CK Life Sciences announce AI-empowered tumour vaccine R&D in China

Chinese firm XtalPi is embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison Group....

November 25, 2022 | Friday | News
IVI, ST Pharm exchange MoU on clinical development of COVID-19 vaccine

The International Vaccine Institute (IVI) and ST Pharm have exchanged a Memorandum of Understanding (MoU) to establish a...

November 25, 2022 | Friday | News
SK bioscience announces KRW 3 Bn donation to IVI to support advancement of global vaccine R&D

SK bioscience, a leading vaccine manufacturer based in the Republic of Korea and a key partner of the International Vacc...

November 18, 2022 | Friday | News
Australia offers new nasal vaccine strategy to improve COVID-19 protection

Researchers from the Centenary Institute and the University of Sydney in Australia have developed a new nasal vaccinatio...

November 17, 2022 | Thursday | News
Lemonex, IVI exchange MoU on joint vaccine development in Korea

The International Vaccine Institute (IVI), in South Korea, has signed a memorandum of understanding (MOU) with Lemonex, ...

November 14, 2022 | Monday | News